Introduction
============

One of the most striking aspects of inhibitory synaptic circuits is the remarkable diversity of GABAergic systems. GABAergic interneurons occur in many different subtypes, that play exquisitely precise functions in neural networks (Markram et al., [@B93]). Each type of interneuron is highly selective, making synapses with particular populations of target cells and only with specific subcellular compartments (Huang et al., [@B56]). Moreover, the diversity of GABAergic interneurons matches a corresponding multiplicity of synaptic and extrasynaptic GABA~A~ receptor (GABA~A~R) subtypes, that support neural circuit operations under an extensive range of behavior-dependent brain states (Monyer and Markram, [@B104]; Freund and Katona, [@B35]; Klausberger and Somogyi, [@B73]; Olsen and Sieghart, [@B107]). For example, in hippocampal and cortical circuits, basket cells containing either parvalbumin (PV) or cholecystokinin (CCK) target the cell body of pyramidal cells at synapses containing mainly α1β2/3γ2 GABA~A~Rs, which display fast kinetics of deactivation, or α2β2/3γ2 GABA~A~Rs, which have slower kinetics compared to receptors containing the α1 subunit (Klausberger et al., [@B72]; Klausberger and Somogyi, [@B73]). While PV-basket cells appear to control the temporal coordination of principal neurons and network oscillations, CCK-positive interneurons modulate synchronous activities by integrating subcortical and local modulatory signals (Freund and Katona, [@B35]; Sohal et al., [@B136]; Thomson and Jovanovic, [@B148]). Notably, these differences can be extended to the level of pathology, as the two types of GABA~A~Rs appear to be implicated in different types of neurological and psychiatric disorders (Lewis et al., [@B86]; Freund and Katona, [@B35]). Similarly, genetic manipulations of individual GABA~A~R subunits in mice produce selective alterations in behavior, reinforcing the idea that specific neuronal networks characterized by respective GABA~A~R subtypes are involved in the regulation of defined behavioral patterns (McKernan et al., [@B96]; Möhler, [@B102], [@B103]; Whiting, [@B160]).

This extraordinary diversity contrasts with the apparent simplicity in the ultrastructural appearance of GABAergic synapses. When observed in the electron microscope, GABAergic synapses fit in the symmetric, or Gray's type II category (Gray, [@B47]; Colonnier, [@B26]; Peters and Palay, [@B116]). These synapses are characterized by a thin postsynaptic density (PSD), similar in size to the presynaptic active zone. In contrast, glutamatergic synapses belong to the asymmetric, or Gray's type I group, which is distinguished by a prominent PSD. Asymmetric synapses also show a conspicuous electron dense material in the synaptic cleft, which is less obvious in symmetric synapses. Not surprisingly, the morphological differences between type I and type II synapses are proportional to their molecular complexity. Proteomic studies of the excitatory PSD have revealed a number of proteins greater than 1000 (Collins et al., [@B25]; Bayés et al., [@B8]), which exceeds by two orders of magnitude the number of molecules that have been found in the inhibitory PSD (Lüscher and Keller, [@B90]; Charych et al., [@B20]). It would be hazardous, however, to conclude that all GABAergic synapses share the same basic molecules and mechanisms to sustain their exquisite specificity. In this essay, we review recent work that points to a remarkable heterogeneity of the molecular machinery that regulates GABAergic synaptogenesis *in vivo* and we provide a personal view of the mechanisms that may underlie synapse specificity during the development of neural circuits. Understanding these mechanisms is of interest for both basic and clinical neuroscience, as disruption of inhibitory synapse development is now regarded as a major cause of brain disease (Lewis et al., [@B86]; Südhof, [@B140]; Charych et al., [@B20]). A detailed description of the molecular organization of GABAergic synapses falls outside the scope of this paper and can be found in other excellent review articles (Lüscher and Keller, [@B90]; Tretter and Moss, [@B149]). Here we rather focus on the evidence that the diversity of GABAergic synapses may be generated by the interplay of multiple molecular mechanisms with partially overlapping functions. We also discuss the importance of a classification scheme that could be used to identify distinct types of synapses based on the differential expression of groups of interacting proteins.

Postsynaptic Scaffolds of Inhibitory Synapses
=============================================

One of the main achievements in the field of synapse research has been the characterization of the molecular components of the PSD. Molecular investigations of glutamatergic synapses have shown that the PSD is a specialized microdomain characterized by core scaffolding proteins, such as PSD-95, that link glutamate receptors to the subsynaptic cytoskeleton and also interact with different types of regulatory proteins and with cell adhesion molecules via specific PDZ domains (Kennedy, [@B65]; Ziff, [@B169]; O'Brien et al., [@B106]; Garner et al., [@B40]; Kim and Sheng, [@B66]; Boeckers, [@B12]). Importantly, there is increasing evidence that protein--protein interactions within the PSD are not static and that dynamic modulation of the PSD provides a mechanism for the regulation of synaptic plasticity (Scannevin and Huganir, [@B129]; Kim et al., [@B67]; Steiner et al., [@B138]). The inhibitory PSD cannot be readily isolated, and progress in understanding its molecular composition has lagged behind that of excitatory synapses. The multi-domain, 93 kDa protein gephyrin has emerged as a major scaffolding molecule of the inhibitory PSD (Kneussel and Betz, [@B76]; Fritschy et al., [@B36]). Here we briefly summarize the proposed functions of gephyrin and we describe other scaffolding molecules that may contribute to assemble postsynaptic specializations in at least some subtypes of inhibitory synapses.

Gephyrin
--------

Gephyrin was originally copurified with the glycine receptor (GlyR; Pfeiffer et al., [@B117]), and was later found also at postsynaptic sites of GABAergic synapses (Sassoè-Pognetto et al., [@B126]; Sassoè-Pognetto and Fritschy, [@B125]). This molecule lacks PDZ domains, but can form aggregates by spontaneous oligomerization, although the precise mechanisms by which gephyrin forms postsynaptic scaffolds is still unresolved (for review, see Fritschy et al., [@B36]). Gephyrin binds a cytoplasmic loop of the GlyR β subunit (Meyer et al., [@B97]), and is essential for postsynaptic clustering of GlyRs (Kirsch et al., [@B71]; Feng et al., [@B33]). This scaffold protein also contributes to stabilize postsynaptic GABA~A~Rs, as its knockdown in cultured neurons causes a disruption of GABA~A~R clusters (Essrich et al., [@B31]; Yu et al., [@B165]). Similarly, knockout of the gephyrin gene in mice results in an extensive loss of postsynaptic GABA~A~R aggregates (Kneussel et al., [@B74], [@B75]; Fischer et al., [@B34]; Lévi et al., [@B85]).

The precise mechanisms by which gephyrin clusters GABA~A~Rs are poorly understood, although there is evidence that this molecule restrains the lateral mobility of the receptors in the plasma membrane (Jacob et al., [@B60]; Thomas et al., [@B147]). Most likely, this function involves interactions with the cytoskeleton, as gephyrin binds with high affinity polymerized tubulin (Kirsch et al., [@B70]; Kirsch and Betz, [@B69]) and serves as an adaptor for regulators of microfilament dynamics (Mammoto et al., [@B91]; Giesemann et al., [@B43]; Bausen et al., [@B7]). Interestingly, the clustering of gephyrin and GABA~A~Rs are to some extent mutually dependent on each other, since synaptic gephyrin clusters are disrupted after deletion of GABA~A~Rs (Essrich et al., [@B31]; Schweizer et al., [@B133]; Li et al., [@B87]; Kralic et al., [@B80]; Studer et al., [@B139]). Alldred et al. ([@B1]) have identified the fourth transmembrane domain of the GABA~A~R γ2 subunit as essential to mediate postsynaptic clustering of GABA~A~Rs, whereas the major γ2 cytoplasmic loop is required for recruitment of gephyrin to GABA~A~R clusters. Direct interactions between gephyrin and the GABA~A~R α2 and α3 subunits have emerged only recently (Tretter and Moss, [@B149]; Saiepour et al., [@B123]). The binding of gephyrin to the α subunits appears to be detergent sensitive, which may explain why it has been remarkably difficult to reveal these interactions using biochemical approaches. However, whether gephyrin binding to GABA~A~Rs involves multiple interactions with distinct α and γ subunits is presently unclear. The relevance of the numerous gephyrin isoforms generated by alternative splicing is also not understood (Paarmann et al., [@B108]; Fritschy et al., [@B36]). Moreover, gephyrin function may depend on post-translational modifications. Indeed, recent studies indicate that phosphorylation of gephyrin at specific residues contributes to regulate the anchoring of GlyRs and GABA~A~Rs at postsynaptic sites (Zita et al., [@B170]; Charrier et al., [@B19]; Tyagarajan et al., [@B150]).

A still unresolved issue is whether gephyrin contributes equally to the clustering of all major subtypes of synaptic GABA~A~Rs (that is receptors that are highly concentrated in the postsynaptic membrane and mediate phasic inhibition). Extensive experimental evidence indicates that receptors containing a γ2 subunit in association with two α and two β subunits (α1β2/3γ2, α2β2/3γ2, and α3β2/3γ2) are the predominant types of synaptic GABA~A~Rs (for review, see Lüscher and Keller, [@B90]; Farrant and Nusser, [@B32]). The analysis of spinal cord sections, retina organotypic cultures, and cultured hippocampal neurons derived from gephyrin knockout mice lead to the idea that gephyrin mediates the postsynaptic accumulation of GABA~A~Rs containing the α2 or the α3 subunit, and suggested the existence of additional clustering mechanisms (Fischer et al., [@B34]; Kneussel et al., [@B75]; Lévi et al., [@B85]). However, in the brain gephyrin colocalizes with all major types of postsynaptic GABA~A~Rs containing either the α1, α2, or α3 subunit (Sassoè-Pognetto et al., [@B127]), indicating that its function is not restricted to α2 and α3-containing synapses. Because gephyrin knockout mice die at birth (Feng et al., [@B33]), a better appreciation of gephyrin function at distinct types of GABAergic synapses may derive from the study of mouse models with conditional deletion of this protein in selected populations of neurons characterized by the expression of distinct GABA~A~R subtypes. The complex situation regarding the role of gephyrin in the clustering of different GABA~A~Rs may also be explained by redundancy between multiple clustering factors with partially overlapping synaptic expression profiles (see below).

The dystrophin--glycoprotein complex
------------------------------------

Another postsynaptic scaffold that is present in some GABAergic synapses is dystrophin. This protein belongs to the dystrophin--glycoprotein complex (DGC), a large, membrane-spanning protein complex that links the cytoskeleton to the extracellular matrix (Ervasti and Campbell, [@B30]; Blake and Kröger, [@B11]; Waite et al., [@B158]). Dystrophin is derived from a large gene with at least seven internal promoters that enable the expression of several distinct isoforms (for review see Perronnet and Vaillend, [@B115]). Interestingly, the full-length (Dp427) isoform is derived from three independent promoters with differential expression in muscle, forebrain, and cerebellar Purkinje cells. The N-terminal domain of dystrophin binds to filamentous actin, whereas the C-terminal domain interacts with dystrobrevins (α and β) and syntrophins (α, β1--2, γ1--2), which are also cytoplasmic constituents of the DGC. Several dystrobrevin-binding elements have been identified, including dysbindin, a protein that has been associated with schizophrenia (Benson et al., [@B9]; Talbot et al., [@B144]). However, immunohistochemical analyses suggest that dysbindin is not enriched at GABAergic synapses (unpublished observations). Syntrophins are adaptor proteins each containing a PDZ domain and two pleckstrin homology (PH) domains mediating interactions with several other proteins, including kinases, ion and water channels, and nNOS (Waite et al., [@B158]). Syntrophin colocalizes with GABA~A~Rs in cultured hippocampal neurons (Brünig et al., [@B17]), however the synaptic localization of endogenous syntrophins in unknown. Of particular interest is the fact that the γ2-syntrophin isoform has been reported to interact with the PDZ binding motif of the adhesion molecules neuroligin 3 and neuroligin 4 (Yamakawa et al., [@B164]), which are present at inhibitory synapses (see below). It is therefore possible that interactions between syntrophins and neuroligins may help organize postsynaptic scaffolds at inhibitory synapses (Figure [1](#F1){ref-type="fig"}).

![**Postsynaptic scaffolds and adhesion molecules of GABAergic synapses**. The diagram is based on reported molecular interactions (see text), some of which remain to be confirmed *in vivo*. Gephyrin, S-SCAM/MAGI-2, and dystrophin are shown in the same postsynaptic specialization, although dystrophin is present in only a subset of GABAergic synapses and the *in vivo* distribution of S-SCAM/MAGI-2 has not been characterized. Gephyrin trimers are believed to aggregate into a submembranous lattice that provides stability to postsynaptic GABA~A~Rs. Gephyrin also binds collybistin (CB) and neuroligin 2 (NL2), that has been proposed to function as a specific activator of collybistin. Cytoskeletal proteins associated with gephyrin, such as Mena/VASP and microtubules, are not shown. Neuroligin 2 bridges the synaptic cleft and binds to neurexins on the presynaptic terminal. Reported interactions between neurexins and GABA~A~Rs are also indicated. Neurexins may also interact with α-dystroglycan (α-DG), thus establishing a link with the dystrophin--glycoprotein complex (DGC). One component of the DGC, syntrophin, has been reported to bind neuroligin 3 and neuroligin 4. Finally, there is evidence that S-SCAM/MAGI-2 may establish a link between neuroligin 2 and the DGC by interacting with the intracellular domain of β-dystroglycan (β-DG).](fncel-05-00004-g001){#F1}

A core component of the DGC is dystroglycan, which is composed of an extracellular α subunit and a transmembrane β subunit, derived by proteolytic cleavage from a single precursor protein (Ibraghimov-Beskrovnaya et al., [@B58]). The β-dystroglycan subunit contains a single transmembrane domain and its cytoplasmic tail binds dystrophin, whereas α-dystroglycan is a secreted glycoprotein that binds to LNS (laminin G, neurexins, and sex hormone-binding globulin)-domain-containing proteins, such as laminin, perlecan, agrin, neurexin, and pikachurin (Bowe et al., [@B14]; Gee et al., [@B41]; Talts et al., [@B146]; Sugita et al., [@B142]; Sato et al., [@B128]). The fact that α-dystroglycan binds neurexin is particularly intriguing, as it suggests that the DGC may mediate *trans*-synaptic interactions between pre- and postsynaptic specializations.

Immunohistochemical analyses have shown that the DGC is present in a subset of GABAergic synapses, specifically in cerebellar Purkinje cells and in forebrain pyramidal neurons (Knuesel et al., [@B77]; Sekiguchi et al., [@B134]; Briatore et al., [@B15]). Interestingly, both *in vitro* and *in vivo* analyses have shown that the synaptic localization of dystrophin and dystroglycan are independent of GABA~A~Rs and gephyrin, suggesting that the DGC has the capacity to self-assemble at postsynaptic sites (Brünig et al., [@B17]; Lévi et al., [@B84]; Patrizi et al., [@B113]). The studies that have investigated the function of the DGC at GABAergic synapses have generated partially conflicting results. Deletion of dystroglycan in cultured hippocampal neurons caused a loss of postsynaptic dystrophin, but did not affect the localization of gephyrin and GABA~A~Rs (Lévi et al., [@B84]). In contrast, *in vivo* analyses of *mdx* mice, that lack the full-length version of dystrophin, revealed a selective deficit in the synaptic clustering of GABA~A~Rs, but not gephyrin, in cerebellum, hippocampus, and amygdala (Knuesel et al., [@B77]; Sekiguchi et al., [@B134]; Vaillend et al., [@B154]). Similar results have been reported in the cerebellum of double knockout mice lacking both α and β dystrobrevins (Grady et al., [@B44]). The selective loss of GABA~A~R clusters, but not gephyrin clusters in *mdx* mice is surprising, also considering that deletion of GABA~A~Rs from Purkinje cells causes a severe defect in the clustering of gephyrin (Kralic et al., [@B80]) without affecting dystrophin and dystroglycan (Patrizi et al., [@B113]). However, there is extensive electrophysiological evidence indicating that an intact DGC is required for normal GABAergic inhibition (Anderson et al., [@B2]; Kueh et al., [@B81]; Sekiguchi et al., [@B134]). In short, the available data indicate that the DGC is involved in modulating synaptic function in a subset of GABAergic synapses. However, the precise organization of the synaptic DGC and the specific contribution of its molecular constituents require further investigations.

S-SCAM/MAGI-2
-------------

According to a recent study, the synaptic scaffolding molecule (S-SCAM)/membrane-associated guanylate kinase with inverted organization (MAGI)-2 localizes at inhibitory synapses in rat primary hippocampal neurons (Sumita et al., [@B143]). This is surprising, because S-SCAM/MAGI-2 has a molecular organization similar to PSD-95, harboring multiple PDZ domains, a guanylate kinase, and two WW domains. S-SCAM/MAGI-2 is also present at glutamatergic synapses, where it interacts with NMDA receptors, neuroligin 1, and β-catenin (Hirao et al., [@B53]; Iida et al., [@B59]). At GABAergic synapses, it has been reported that S-SCAM/MAGI-2 can interact with β-dystroglycan and neuroligin 2, suggesting that this scaffold molecule may provide a link between the DGC and the neurexin--neuroligin adhesion system (Sumita et al., [@B143]). Thus it appears that S-SCAM/MAGI-2 and syntrophins may mediate selective interactions between the DGC and, respectively, neuroligin 2 and neuroligins 3 and 4 (Figure [1](#F1){ref-type="fig"}). Research on S-SCAM/MAGI-2 is still at its beginnings, but it may lead to the discovery of new mechanisms underlying the assembly of the inhibitory PSD. It will be important to characterize the spatio-temporal profile of S-SCAM/MAGI-2 expression in relation to the other molecular constituents of GABAergic postsynapses. In addition, it will be of primary interest to investigate the possible redundancy of *trans*-synaptic signals mediated by the DGC and the neurexin--neuroligin adhesion system. More in general, *in vivo* analyses are needed to get a clear picture of the endogenous distributions of these different scaffolding systems and to help dissecting their specific roles in different populations of synapses.

Variability in the Mechanisms That Regulate the Postsynaptic Accumulation of Gephyrin
=====================================================================================

While gephyrin is expressed almost ubiquitously at inhibitory synapses, recent studies have evidenced an unexpected variability in the mechanisms that control its synaptic localization. For example, in cerebellar Purkinje cells gephyrin is expressed initially at all GABAergic synapses, however during postnatal development gephyrin clusters disappear from perisomatic synapses and remain exclusively at axodendritic contacts (Viltono et al., [@B157]). While the reasons for this differential regulation are unclear, the loss of gephyrin is mirrored by a structural reorganization of perisomatic synapses, consisting in a reduction in the size of GABA~A~R clusters and in the length of synaptic appositions.

One protein implicated in the recruitment of gephyrin to postsynaptic specializations is the GEF (guanine nucleotide exchange factor) collybistin, that was identified as a gephyrin-binding protein in a two-hybrid screening (Kins et al., [@B68]). Collybistin, like other GEFs, is characterized by an N-terminal *src* homology 3 (SH3) domain, a catalytic tandem Dbl homology (DH) domain and a PH domain. It is believed that collybistin participates in the membrane targeting of gephyrin by binding membrane lipids through its PH domain (Harvey et al., [@B50]; Reddy-Alla et al., [@B121]). Different collybistin isoforms (CB1-3) have been identified, which are created by alternative splicing of exons encoding the SH3 domain and three alternate C termini (Kins et al., [@B68]; Harvey et al., [@B50]). Interestingly, expression studies have shown that the SH3 domain negatively regulates collybistin function (Kins et al., [@B68]; Harvey et al., [@B50]). However, most endogenous collybistin isoforms harbor this region, suggesting that collybistin activity requires protein--protein interactions at the SH3 domain (Kins et al., [@B68]; Harvey et al., [@B50]). Indeed, recent investigations have shown that the synaptic adhesion molecules neuroligin 2 and neuroligin 4 can bind to and activate collybistin by relieving the SH3-mediated inhibition (Poulopoulos et al., [@B120]; Hoon et al., [@B55]). In addition, all neuroligin isoforms have in their cytoplasmic domain a conserved gephyrin-binding motif that contributes to recruit gephyrin to synapses. It has been proposed that by interacting with gephyrin and collybistin neuroligin 2 can act as a nucleation site for the formation of postsynaptic gephyrin scaffolds that recruit GABA~A~Rs at postsynaptic sites (Poulopoulos et al., [@B120]). On the other hand, knockout of neuroligin 2 has only a relatively small effect on the clustering of gephyrin and GABA~A~Rs, specifically at perisomatic synapses of hippocampal neurons (Poulopoulos et al., [@B120]). In contrast, deletion of collybistin or GABA~A~Rs causes an extensive loss of gephyrin clusters (Essrich et al., [@B31]; Li et al., [@B87]; Kralic et al., [@B80]; Studer et al., [@B139]; Papadopoulos et al., [@B111]; Patrizi et al., [@B113]). These observations question the importance of neuroligin 2 as a major physiological clustering factor for gephyrin and collybistin and suggest that there could be multiple pathways capable of activating collybistin with differential cellular and subcellular specificity.

Mouse genetic studies have revealed that *in vivo* collybistin is required for the initial localization and maintenance of gephyrin and GABA~A~R clusters in a subset of inhibitory synapses in selected brain regions, particularly in the hippocampus and basolateral amygdala (Papadopoulos et al., [@B111], [@B110]). Surprisingly, deletion of collybistin did not affect the organization of GABAergic synapses in other regions, nor that of glycinergic synapses. These findings indicate that the mechanisms that control the assembly of the inhibitory PSD are region and synapse-specific. This selectivity may be explained by the fact that the expression of collybistin at inhibitory synapses is highly heterogeneous. In the retina, collybistin is preferentially colocalized with α2-GABA~A~Rs, and shows limited localization at synapses containing other GABA~A~R subtypes or GlyRs (Saiepour et al., [@B123]). Similarly, in brain circuits collybistin has been found in only a subset of gephyrin-positive synapse, although no specific association with particular GABA~A~R subtypes was found (unpublished observations). These observations suggest that other GEFs or unknown clustering factors may also contribute to cluster gephyrin at postsynaptic sites. Interestingly, a recent study has revealed that SynArfGEF (also known as BRAG3 or IQSEC3), a member of the A-resistant Arf-GEF/IQSEC3 family, localizes at postsynaptic specializations of GABAergic and glycinergic synapses and can interact with dystrophin and S-SCAM/Magi-2 (Fukaya et al., [@B39]). Thus, SynArfGEF is another GEF expressed at inhibitory synapses, although its precise function remains to be determined. It will be important to understand whether SynArfGEF, like collybistin, is associated with selected subtypes of inhibitory synapses, and whether these two GEFs have differential or partially overlapping distributions.

Synaptic Specificity Depends on Multiple Mechanisms
===================================================

A crucial and still open question in developmental neurobiology is to decipher the mechanisms that ensure the formation of functional connections between appropriate synaptic partners characterized by distinct molecular signatures. A large number of studies in both vertebrate and invertebrate nervous systems have shown that the specificity of synapses depends on multiple mechanisms, including homophilic and heterophilic interactions between adhesion molecules, secreted synaptic organizers, antisynaptogenic molecules, interactions with guidepost and/or glial cells, temporally restricted expression of transcription factors, and defined patterns of neuronal activity (for a recent review see Margeta and Shen, [@B92]). To illustrate the remarkable variety of the mechanisms that give rise to connectional specificity, we refer to recent work on cerebellar Purkinje cells. These neurons receive GABAergic inhibition mainly from basket cells, that target the cell body and the axon initial segment (AIS), and from stellate cells, that innervate exclusively the dendritic shafts (Palay and Chan-Palay, [@B109]). Both types of synapse express the same GABA~A~R subtype containing the α1 subunit (Fritschy et al., [@B37]). Studies in transgenic mouse models have shown that stellate and basket cells use different molecular cues to innervate distinct subcellular domains of Purkinje cells. The targeting of basket axons to the AIS depends on a subcellular gradient of neurofascin 186, a cell adhesion molecule of the L1 immunoglobulin family (Ango et al., [@B3]). This gradient requires ankyrinG, a membrane adaptor protein that is restricted to the AIS and recruits neurofascin. In ankyrinG-deficient Purkinje cells, the neurofascin gradient is abolished, and basket axons lose their directional growth along Purkinje cells, resulting in impaired synapse formation. On the other hand, the formation of stellate cell synapses depends on close homolog of L1 (CHL1), another member of the same family of adhesion molecules, localized along Bergmann glia fibers (Ango et al., [@B4]). Thus, different members of the L1 family of cell adhesion molecules contribute to axon patterning and subcellular synapse organization in different types of interneurons, although it seems that these molecules are more directly involved in axon guidance rather than in mediating synapse formation.

There is also evidence that GABA~A~Rs play a remarkably selective role in the refinement of perisomatic and axodendritic synapses in Purkinje cells. Deletion of GABA~A~Rs from Purkinje cells causes a selective decrease in the density of axodendritic synapses without altering the number of perisomatic synapses (Fritschy et al., [@B37]; Patrizi et al., [@B113]). Notably, the reduced axodendritic innervation is accompanied by the appearance of numerous heterologous contacts between GABAergic axon terminals and Purkinje cell spines, which retain an asymmetric PSD typical of glutamatergic synapses (Fritschy et al., [@B37]).

These examples highlight two important aspects of synaptic specificity. First, the selectivity of connections does not depend on a hard-wired process based on exclusive cellular interactions, but rather results from a mechanism of selection among potential synaptic partners. In Purkinje cells, the silencing of GABAergic transmission is sufficient to boost ectopic synapses on spines, suggesting that in this specific case activity-dependent competition is a major determinant of synaptic specificity. Second, different synapses are subject to different regulation, implying that mutations that perturb synapse development in some populations of synapses may leave other synapses unaffected. This heterogeneity must be understood before common principles of synaptogenesis can be defined.

Complex Organization of Adhesion Molecules at Inhibitory Synapses
=================================================================

Once a synaptic adhesion has been established, it is essential that synaptic specializations recruit the correct complement of pre- and postsynaptic molecules, including the correct types of neurotransmitter receptors and their anchoring proteins. In the case of GABAergic synapses, it is still unknown how postsynaptic neurons cluster distinct types of GABA~A~Rs at synapses that can be located only a few micrometers apart. Selective interactions between pre- and postsynaptic adhesion molecules have been invoked to explain the selectivity in the segregation of different GABA~A~Rs (Thomson and Jovanovic, [@B148]). Indeed, there seems to be enough variability in the different families of synaptic adhesion molecules to support this function (Scheiffele, [@B130]; Yamagata et al., [@B163]; Washbourne et al., [@B159]; Craig et al., [@B27]; Piechotta et al., [@B118]; Dalva et al., [@B29]; Arikkath and Reichardt, [@B5]; Biederer and Stagi, [@B10]; Brose, [@B16]; Siddiqui and Craig, [@B135]; Tallafuss et al., [@B145]), although none of the known adhesion proteins appears to have a selective localization that would be compatible with a role in segregating distinct GABA~A~Rs to different synapses. Here we discuss the possibility that synapse diversity may result from the differential co-expression of multiple adhesion molecules with partially overlapping distributions.

Neuroligin 2 is arguably the best characterized adhesion molecule of GABAergic synapses. This molecule belongs to a family of four (in rodents) isoforms, which appear to segregate into distinct types of excitatory and inhibitory synapses (Song et al., [@B137]; Craig and Kang, [@B28]). Neuroligin 2 is localized at postsynaptic sites of inhibitory synapses throughout the brain (Varoqueaux et al., [@B155]; Patrizi et al., [@B113]), and promotes GABAergic synaptogenesis *in vitro* (Graf et al., [@B45]; Chih et al., [@B22]; Chubykin et al., [@B23]). Moreover, neuroligin 2 knockout mice exhibit selective deficits in GABAergic neurotransmission, indicating that this adhesion molecule is required for normal synapse development (Chubykin et al., [@B23]; Hoon et al., [@B54]; Jedlicka et al., [@B61]).

Recent studies have evidenced a complex organization of neuroligins at inhibitory synapses. While NL2 is present in practically all inhibitory synapses throughout the brain, other neuroligin isoforms have a more restricted distribution. Thus, NL4 is mainly associated with glycinergic synapses (Hoon et al., [@B55]), whereas NL3 is coexpressed with NL2 in subsets of GABAergic synapses (Budreck and Scheiffele, [@B18]; Patrizi et al., [@B114]). These observations indicate that differential expression of neuroligins may confer specific functional properties to individual synapses, although the contribution of each individual neuroligin isoform remains unclear. Interestingly, recent research has indicated that NL2 has quite selective functions at GABAergic synapses, despite its broad distribution. In hippocampal pyramidal neurons, deletion of NL2 decreases the amplitude of IPSCs evoked from PV-positive interneurons, but has no effect on IPSCs evoked from somatostatin-positive cells (Gibson et al., [@B42]). A similar level of selectivity has been reported also for other cell adhesion molecules. For example, perturbation of the neural cell adhesion molecule (NCAM) produces selective effects on GABAergic synapses in frontal and cingulate cortex and in the amygdala, but not in hippocampus (Pillai-Nair et al., [@B119]). Together, these data reveal an unexpected variability in the synaptic properties conferred by individual cell adhesion molecules and provide support to the idea that synaptic specificity may be encoded by multiple interactions between selective combinations of synaptogenic proteins.

It is generally assumed that neuroligins promote synapse maturation by interacting with presynaptic neurexins (Ushkaryov et al., [@B153]; Graf et al., [@B45]; Chih et al., [@B21]; Kang et al., [@B63]). Neurexins occur in six different isoforms (three longer α-neurexins and three shorter β-neurexins), that are further subject to alternative splicing, giving rise to several distinct variants that can bind with different affinities to multiple types of postsynaptic partners, including neuroligins, LRRTMs (leucine-rich repeat transmembrane neuronal proteins), neurexophilins, and the Cbln1--GluD2 (cerebellin 1-glutamate receptor δ2) complex (Ullrich et al., [@B152]; Missler and Südhof, [@B100]; Koehnke et al., [@B79]; Siddiqui and Craig, [@B135]; Uemura et al., [@B151]; Wright and Washbourne, [@B162]). In particular, the presence or the absence of an insert at splice site 4 (S4) appears to be an important determinant of binding partner selectivity (for review, see Craig and Kang, [@B28]; Siddiqui and Craig, [@B135]). Co-culture studies support a preferential role of α-neurexins(+S4) in mediating GABAergic synaptogenesis (Boucard et al., [@B13]; Chih et al., [@B22]; Kang et al., [@B63]). Likewise, knockout of all α-neurexins decreases considerably the density of GABAergic synapses in cortex (Missler et al., [@B101]). Interestingly, α neurexins can also interact with α-dystroglycan (Sugita et al., [@B142]), which is present in a subset of GABAergic synapses as discussed above. Neurexins have also been reported to interact directly with GABA~A~Rs, although the importance of these interactions for synapse development is still unclear (Zhang et al., [@B168]). In summary, although there is clear evidence that both neuroligin 2 and α-neurexins(+S4) promote GABAergic synaptogenesis *in vitro*, the extensive alternative splicing and numerous binding partners of neurexins suggest that these molecules may regulate synapse development by multiple, and not necessarily shared, mechanisms. As novel studies evidence that neuroligins can regulate glutamatergic synaptogenesis by neurexin independent mechanisms (Ko et al., [@B78]) and, *vice versa*, that neurexins induce the formation of glutamatergic synapses by interacting with postsynaptic molecules other than neuroligins (Uemura et al., [@B151]; Matsuda and Yuzaki, [@B95]), it appears reasonable to re-evaluate the relevance of neurexin--neuroligin interactions in the context of inhibitory synapse development. It will also be of primary interest to understand what is the expression profile of the different neurexin isoforms in distinct types of excitatory and inhibitory synapses.

Synaptic Cleft Proteins Provide a Further Level of Complexity
=============================================================

An emerging concept is that proteins localized in the synaptic cleft may act bi-directionally to coordinate selective interactions between the pre- and postsynaptic compartments. By itself, this is not a new idea, as it is well established that at the neuromuscular junction secreted proteins, such as agrin and laminin, serve as synaptic organizers (Kummer et al., [@B82]; Witzemann, [@B161]; Rushton et al., [@B122]). Recently, a novel class of secreted molecules that link pre- and postsynaptic specializations has been characterized in the cerebellar cortex. Specifically, it has been shown that Cbln1 acts as a crucial synaptic organizer that is required for the formation and maintenance of glutamatergic synapses made by parallel fibers with Purkinje cell spines (Yuzaki, [@B167]). Cbln1 is a glycoprotein of the C1q family that is secreted from cerebellar granule cells. Mice lacking Cbln1 are ataxic and show a surprising similarity to mice lacking the δ2 glutamate receptor (GluD2), which is expressed selectively in Purkinje cells. Both these mutants have a remarkable (∼50%) reduction in the number of parallel fiber-Purkinje cell synapses, with the remaining synapses showing a mismatch between PSDs and presynaptic active zones, as well as impaired LTD (Kashiwabuchi et al., [@B64], Kurihara et al., [@B83], Hirai et al., [@B52]). The similarities in the structural and functional abnormalities observed in *Cbln1*-null and *GluD2*-null mice have suggested that these two molecules are engaged in a common signaling pathway. Indeed it has been demonstrated that Cbln1 binds to the N-terminal domain of GluD2 (Matsuda et al., [@B94]), and that the Cbln1--GluD2 complex mediates synapse formation by interacting selectively with neurexins(+S4) (Uemura et al., [@B151]; Figure [2](#F2){ref-type="fig"}).

![**Proposed *trans*-synaptic interactions mediated by synaptic cleft glycoproteins**. At parallel fiber-Purkinje cell synapses (left), Cbln1 forms a ternary complex with neurexin variants containing the S4 insert and postsynaptic GluRδ2 receptors (modified from Uemura et al., [@B151]). At some GABAergic synapses (right), α-dystroglycan (α-DG) may establish a link between α-neurexins and the postsynaptic dystrophin--glycoprotein complex through the transmembrane β-dystroglycan isoform (β-DG). Glycan side chains of Cbln1 and α-DG may also mediate multiple interactions with extracellular matrix molecules.](fncel-05-00004-g002){#F2}

These new exciting findings show that secreted proteins can act as divalent ligands linking pre- and postsynaptic transmembrane components. Accordingly, the synaptic cleft can be regarded as the site in which secreted factors and cell adhesion molecules mediate *trans*-synaptic interactions that may contribute to encode synaptic specificity. For example, the ternary interaction between neurexin(+S4), Cbln1 and GluD2 may represent a "protein code" specific for parallel fiber-Purkinje cell synapses (Uemura et al., [@B151]). Notably, there is evidence that Cbln1 and the closely related Cbln2 can interact with neurexins and mediate synapse formation not only in cerebellum but also in forebrain regions (Matsuda and Yuzaki, [@B95]). Co-culture analyses have shown that Cbln1 and Cbln2 induce preferentially inhibitory presynaptic differentiation by interacting with neurexin variants containing S4, although the postsynaptic partners remain unknown (Joo et al., [@B62]). It is therefore reasonable to assume that differential interactions of neurexin variants with neuroligins, Cbln and LRRTMs may be involved in specifying distinct types of excitatory and inhibitory synapses. By analogy, we suggest that *trans*-synaptic interactions mediated by α-dystroglycan may constitute a molecular code for a specific subset of GABAergic synapses (Figure [2](#F2){ref-type="fig"}).

In short, cross-interactions between synaptic cleft proteins and cell adhesion molecules provide an additional level of complexity that could be exploited by neurons to functionally specify synapses. It is now a key task to increase our understanding of the synaptic extracellular matrix or synaptomatrix (Vautrin, [@B156]). Ultrastructural analyses have shown that this material is particularly dense, even denser than the neuronal cytosol, and is characterized by periodically organized complexes, suggesting a regular arrangement of cleft proteins (Zuber et al., [@B171]). Resolving the molecular interactions that occur in the synaptomatrix is likely to provide important insights into the mechanisms that underlie the formation and specificity of synapses.

A Molecular Catalog of Inhibitory Synapses
==========================================

The studies revised above have revealed an unexpected complexity in the molecules and mechanisms that control the assembly and specificity of inhibitory synapses during the formation of neural circuits. An important insight that has emerged from these investigations is that not all synaptic proteins are expressed equally at all inhibitory synapses, suggesting that synapse diversity is produced by unique combinations of synaptic molecules with partially overlapping localizations and functions. The combinatorial expression of distinct sets of synaptic molecules may be regarded as a signature that identifies individual synapses and could be used to generate a molecular-based system of synapse categorization (Grant, [@B46]). A molecular catalog could be used to identify distinct types of synapses based on the differential expression of groups of interacting proteins, each contributing to specific aspects of synapse organization and physiology.

While the tremendous complexity of glutamatergic synapses poses a formidable challenge toward the accomplishment of a synapse catalog (Grant, [@B46]), a molecular characterization of inhibitory synapses appears to be within reach. A main obstacle is that our current list of synaptic proteins is not yet complete. Therefore a crucial step will be the identification of all proteins, including their splice variants and post-translational modifications. Expression screenings in co-culture systems represent a useful method for the identification of novel families of synaptogenic molecules (Paradis et al., [@B112]; Linhoff et al., [@B89]). On a larger scale, existing proteomic methods, such as mass spectrometry and protein array tools, can be applied to reveal protein--protein interactions (Husi et al., [@B57]; Schweitzer et al., [@B132]; Yuk et al., [@B166]; Collins and Choudhary, [@B24]). Bioinformatics tools could also be employed to generate hypothesis of interactions that could be verified experimentally and to construct interaction maps and models that could be used to predict the effects of mutations of single proteins (Armstrong et al., [@B6]).

Ideally, a categorization of synapses based on molecular markers should be combined with detailed knowledge of synaptic connectivity *in situ*, the ultimate goal being a convergence of synaptic proteomics with connectomics (Lichtman and Sanes, [@B88]). Considering the diversity and specificity of synapses, a full appreciation of their molecular complexity can be achieved only by microscopic analyses aimed at individual synapses. In this context, immunofluorescence methods are of particular interest because they combine high sensitivity with adequate resolution, and because they are suitable for large-scale analyses of protein distribution (Schneider Gasser et al., [@B131]; Sassoè-Pognetto, [@B124]). Moreover, labeling with multiple antibodies allows to determine whether two or more synaptic proteins colocalize at specific synapses. Recent developments, such as the advent of super-resolution light microscopy (Gustafsson, [@B49]; Hell, [@B51]; Nägerl et al., [@B105]), have considerably expanded the analytical power of immunofluorescence microscopy. In particular, array tomography is a new proteomic imaging method that exploits a combination of light and electron microscopic approaches (Micheva and Smith, [@B99]). This method consists in immunolabeling and imaging ordered arrays of ultrathin (50--200 nm), resin-embedded serial sections on glass microscopic slides, resulting in the acquisition of very large volume images at high resolution. Moreover, antibodies can be eluted and the sections restained a number of times thus allowing the detection of a large number of antigens in the same sample. Because of its proteomic capabilities and high resolution, array tomography represents a useful method for large-scale exploration of synaptic diversity. This method has been recently used to determine the composition of glutamatergic and GABAergic synapses in somatosensory cortex of Line-H-YFP Thy-1 transgenic mice (Micheva et al., [@B98]).

The potential of array tomography and other immunohistochemical methods is limited by the availability of antibodies that can be used to stain brain sections. In many cases the extensive sequence homology between related protein isoforms precludes the generation of specific antibodies. These technical difficulties may be overcome by labeling proteins directly by recombinant fusion protein technologies. For example, in a recent study pH-sensitive pHluorin tagging was used to distinguish the membrane vs. intracellular pools of engineered neurexin 1α and neurexin 1β in cortical organotypic cultures (Fu and Huang, [@B38]). In this study, the pHluorin-tagged neurexin isoforms were expressed in PV-positive interneurons, allowing the visualization of their subaxonal localization and dynamics in a specific subset of GABAergic synapses. In another study, PSD-95--GFP was transfected by *in utero* electroporation in a specific population of cortical pyramidal neurons to monitor *in vivo* the dynamics of PSD-95 clusters using two-photon microscopy (Gray et al., [@B48]). While the expression of a tagged protein in isolated neurons may facilitate the visualization of its subcellular localization, the molecular cataloguing of synapses would require that the tagged proteins are expressed *in vivo* and replicate precisely the distribution patterns and expression levels of the endogenous proteins. Although the technology to perform this is potentially available, there have been no systematic analyses of synaptic protein distribution using this approach.

A full appreciation of the molecular diversity of synapses may help to uncover relationships between molecular composition and functional properties. In this context, the analysis of molecular organization should be complemented by gain or loss-of-function studies aimed at individual synaptic proteins in genetic model organisms. Likewise, a detailed knowledge of synaptic molecular composition may provide an interpretation key for the results obtained in knockout mutants, where the effects of the mutation are often confounded by the co-existence of multiple redundant molecular pathways (Piechotta et al., [@B118]). A synapse catalog could also be used to predict the consequences of mutations in the context of brain pathology and to identify populations of synapses that are likely to be affected in a particular disease (Grant, [@B46]). Finally, it will be of prime interest to consider how synapses vary over time, in particular by comparing synapse organization during the period of development and in mature circuits. As the last two decades have witnessed an impressive advancement in the identification of the molecular constituents of synapses (Südhof and Malenka, [@B141]), a big challenge ahead is to define the spatio-temporal expression profile of the endogenous synaptic proteins, to understand how this large array of molecules assemble into functional units, and to link the molecular data sets with a characterization of the anatomical and physiological diversity of synapses.
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